Eton Pharmaceuticals Inc (ETON)
5.80
+0.12
(+2.11%)
USD |
NASDAQ |
Sep 27, 16:00
5.800
0.00 (0.00%)
Pre-Market: 20:00
Eton Pharmaceuticals Accounts Receivable (Quarterly): 4.873M for June 30, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 4.873M |
March 31, 2024 | 4.24M |
December 31, 2023 | 3.411M |
September 30, 2023 | 3.495M |
June 30, 2023 | 3.084M |
March 31, 2023 | 2.874M |
December 31, 2022 | 1.852M |
September 30, 2022 | 1.498M |
June 30, 2022 | 0.834M |
March 31, 2022 | 0.796M |
December 31, 2021 | 5.471M |
September 30, 2021 | 0.385M |
Date | Value |
---|---|
June 30, 2021 | 0.303M |
March 31, 2021 | 0.30M |
December 31, 2020 | 0.048M |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.205M |
December 31, 2019 | 0.473M |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2020
5.471M
Maximum
Dec 2021
1.797M
Average
0.834M
Median
Jun 2022
Accounts Receivable (Quarterly) Benchmarks
Biomarin Pharmaceutical Inc | 691.23M |
Integra Lifesciences Holdings Corp | 271.16M |
Elutia Inc | 3.518M |
Immuneering Corp | -- |
Journey Medical Corp | 10.46M |